Chemoinformaics analysis of CIS-MUUROL-5-EN-4-BETA-OL
| Molecular Weight | 222.372 | nRot | 1 |
| Heavy Atom Molecular Weight | 196.164 | nRig | 11 |
| Exact Molecular Weight | 222.198 | nRing | 2 |
| Solubility: LogS | -5.265 | nHRing | 0 |
| Solubility: LogP | 4.387 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 42 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 43.1886 |
| nHD | 1 | BPOL | 26.0834 |
| QED | 0.669 |
| Synth | 4.441 |
| Natural Product Likeliness | 2.563 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.001 |
| HIA | 0.005 |
| CACO-2 | -4.383 |
| MDCK | 0.0000166 |
| BBB | 0.964 |
| PPB | 0.920391 |
| VDSS | 1.49 |
| FU | 0.0605263 |
| CYP1A2-inh | 0.171 |
| CYP1A2-sub | 0.696 |
| CYP2c19-inh | 0.088 |
| CYP2c19-sub | 0.936 |
| CYP2c9-inh | 0.233 |
| CYP2c9-sub | 0.571 |
| CYP2d6-inh | 0.015 |
| CYP2d6-sub | 0.659 |
| CYP3a4-inh | 0.198 |
| CYP3a4-sub | 0.515 |
| CL | 9.579 |
| T12 | 0.063 |
| hERG | 0.011 |
| Ames | 0.024 |
| ROA | 0.21 |
| SkinSen | 0.035 |
| Carcinogencity | 0.196 |
| EI | 0.107 |
| Respiratory | 0.521 |
| NR-Aromatase | 0.016 |
| Antiviral | Yes |
| Prediction | 0.88878 |